<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104580">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01743001</url>
  </required_header>
  <id_info>
    <org_study_id>AC-055-305</org_study_id>
    <nct_id>NCT01743001</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome</brief_title>
  <acronym>MAESTRO</acronym>
  <official_title>A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3 Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Actelion</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical study to assess the efficacy, safety, and tolerability of macitentan in subjects
      with Eisenmenger Syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline to Week 16 in exercise capacity, as measured by 6MWD</measure>
    <time_frame>From baseline to Week 16</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to Week 16 in WHO functional class</measure>
    <time_frame>From baseline to Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to Week 16 in dyspnea (assessed by the Borg dyspnea index)</measure>
    <time_frame>From baseline to Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to Week 16 in quality of life (assessed by the SF-36 questionnaire)</measure>
    <time_frame>From baseline to Week 16</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Macitentan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects receive macitentan 10 mg oral tablet once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects receive macitentan-matching placebo oral tablet once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Macitentan 10 mg</intervention_name>
    <description>Macitentan 10 mg oral tablet once daily</description>
    <arm_group_label>Macitentan</arm_group_label>
    <other_name>ACT-064992</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Macitentan-matching placebo oral tablet once daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects:

               -  not participating in the hemodynamic sub-study: males or females ≥ 12 years of
                  age.

               -  participating in the hemodynamic sub-study: males or females ≥ 18 years of age.

          -  Subjects (including those with Down Syndrome [DS]) with confirmed Eisenmenger
             Syndrome [ES] (European Society of Cardiology [ESC] and the European Respiratory
             Society [ERS] guidelines):

               1. Established by echocardiography as:

                    -  Large congenital shunting defect at atrial, ventricular or arterial level*

                    -  and right to left shunt or bi-directional shunt with prevalent right to
                       left direction.

               2. Resting peripheral oxygen saturation (SpO2) ≤ 90% and &gt; 70% (pulse oximetry,
                  room air).

        The lower limit is 65% if a subject is living at an altitude greater than 2500 m above sea
        level.

        *Subjects with any of the following open defects are eligible for the study either as an
        isolated defect or in combination:

          -  atrial septal defect (ASD)

          -  ventricular septal defect (VSD)

          -  partial or complete atrioventricular septal defect (AVSD)

          -  patent ductus arteriosus (PDA)

          -  aortopulmonary window (AP window)

          -  total or partial anomalous pulmonary venous return (TAPVR, PAPVR) The defects may be
             either unoperated or previously palliated surgically (provided significant residual
             defect remains).

        The Steering Committee will review the echocardiography data of all subjects (main study
        and sub study) to confirm eligibility prior to Randomization.

          -  Subjects with the following findings at cardiac catheterization:

               -  Mean resting pulmonary arterial pressure (mPAP) &gt; 25 mmHg

               -  Pulmonary capillary wedge pressure (PCWP) or mean left atrial pressure (LAP) or
                  left ventricular end diastolic pressure (LVED) ≤ 15 mmHg

               -  Pulmonary vascular resistance (PVR) ≥ 800 dyn∙s/cm5 or ≥ 10 Wood units

          -  Subjects with WHO functional class ≥ II.

          -  Subjects able to reliably perform the the 6-minute walk test (6MWT) with a minimum
             distance of 50 m and a maximum distance of 450 m.

        Exclusion Criteria:

        - Main study and hemodynamic sub-study: Any of the following conditions previously known
        or identified via cardiac catheterization or echocardiography:

          -  Pulmonary arterial or venous stenosis &gt; 25% size of native pulmonary artery (PA) or
             pulmonary vein

          -  Severe tricuspid regurgitation in the setting of left to right shunt at the
             ventricular or atrial level

          -  Greater than mild tricuspid stenosis

          -  Intracavitary RV outflow obstruction

          -  Greater than mild mitral stenosis

          -  Intracavitary LV outflow obstruction

          -  Subvalvular or supravalvular aortic stenosis

          -  Aortic coarctation

          -  Greater than moderate mitral regurgitation

          -  Recognized extracardiac systemic venous collaterals to the pulmonary venous
             circulation

          -  Recognized hepatic wedge pressure-inferior vena cava pressure gradient &gt;12 mm Hg

          -  PCWP &quot;v&quot; waves &gt;20 mmHg

          -  Tetralogy of Fallot

          -  Truncus arteriosus

          -  Interrupted aortic arch

          -  Transposition of great arteries

          -  Single ventricle defects: absent AV connection (mitral or tricuspid atresia), double
             inlet AV connections left or right ventricle, functional univentricular heart
             (unbalanced AVSD, hypoplastic RV, double outlet RV), hypoplastic left heart syndrome

          -  Ebstein's anomaly

          -  Severe aortic regurgitation

          -  Pulmonary atresia

          -  PAPVR or TAPVR, ONLY if there is lung hypoplasia or if documentation confirming the
             absence of lung hypoplasia does not exist.

        For subjects participating in the hemodynamic sub-study the following will also be
        considered exclusion criteria:

          -  SVC stenosis &gt;25% size of native vessel

          -  PDA, AP window, TAPVR, PAPVR, or ASD sinus venosus with anomalous pulmonary veins

          -  Down Syndrome

               -  Subjects with deterioration of their clinical status within 3 months prior to
                  Screening or during the Screening period.

               -  Known moderate-to-severe restrictive (i.e., total lung capacity [TLC] &lt; 60% of
                  predicted value) or obstructive lung disease (i.e., forced expiratory volume in
                  one second [FEV1] &lt; 80 % of predicted value, and with FEV1 / forced vital
                  capacity [FVC] &lt; 70%)

               -  Treatment with prostanoids within 1 month prior to Randomization

               -  Subjects who initiated a PDE-5 inhibitor within 1 month prior to Randomization
                  or those on a PDE-5 inhibitor for whom the dose has not been stable within 1
                  month prior to Randomization

               -  Treatment with endothelin receptor antagonists (ERAs) within 1 month prior to
                  Randomization

               -  Subjects who initiated diuretics within 1 week prior to Randomization or
                  subjects whose diuretic treatment has not been stable for at least 1 week prior
                  to Randomization

               -  Subjects being considered for an organ transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ahmanson/UCLA Heart Disease Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford Hospital and Clinic</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital/the Emory Clinic</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnes-Jewish Hosp/Wash Univ School of Med</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children'S Heart Center Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Children'S Hosp - Dept of Cardiology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-2303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gen Hosp Univ Vienna Dept Cardiology</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mhat Nat Card Hosp - Cardiology Clinic</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mhat Nat Card Hosp - Pediatric Clin / Ped Card Dept</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mhat Sveta Anna Clin Card</name>
      <address>
        <city>Sofia</city>
        <zip>1750</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inst Nat Torax, Unidad Cardiopatia Congenitas Del Adulto</name>
      <address>
        <city>Providencia</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Tabancura - Cardio Unit</name>
      <address>
        <city>Santiago</city>
        <zip>7650018</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital, Cardiology Dpt</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wu Han Asia Heart Hosp</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The General Hosp of Shenyang Military Region</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital, Cardiology Dpt</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute&amp;Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Pulmonary Hospital, Dept of Pulmonary Circulation</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp La Timone - Dept Pediatric Cardiology</name>
      <address>
        <city>Marseille Cedex 5</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Laennec - Dept Cardiology</name>
      <address>
        <city>Nantes Cedex 1</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Pompidou - Dept Congenital Cardiac Diseases</name>
      <address>
        <city>Paris Cedex 15</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Cardiology Haut Leveque - Dept Congenital Diseases</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Berlin, Ped Cardiology</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen - Pediatric Heart Center</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uni Heidelberg - Kinderkardiologie</name>
      <address>
        <city>Heidelberg</city>
        <zip>D-69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ahepa University General Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Centre - Pulmonology</name>
      <address>
        <city>Petach Tikvah</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Jantung Negara</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unidad de Investigacion Clin En Med, Sc (Udicem)</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64718</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cardiologia (Inc) Ignacio Chavez</name>
      <address>
        <city>Mexico City</city>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Corazon de Querètaro</name>
      <address>
        <city>Querétaro</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PHC, MAB</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Gdańsk Univ</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-952</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Kraków Univ</name>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Wrocław</name>
      <address>
        <city>Wrocław</city>
        <zip>51-124</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Univ Coimbra - Dpt Cardiology</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-075</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Sta Marta - Dept Cardiology</name>
      <address>
        <city>Lisboa</city>
        <zip>1169-024</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Er Inst For Cardvasc Dis &quot;Prof Dr Cc Iliescu&quot; - Card Ii</name>
      <address>
        <city>Bucuresti</city>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardio Med Srl</name>
      <address>
        <city>Targu-Mures</city>
        <zip>540136</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clin Hosp For Inf and Pulm Dis Victor Babes - Ii Pulm</name>
      <address>
        <city>Timisoara</city>
        <zip>300312</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sci Institute Systemic Problems Cardio Diseases Kemerovo</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russian Cardiology Scientific and Production Complex</name>
      <address>
        <city>Moscow</city>
        <zip>121552</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V. A. Almazov Institute of Cardiology</name>
      <address>
        <city>St Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dedinje Cardiovasc Inst - Cardiovasc Research Ctr</name>
      <address>
        <city>Belgrade</city>
        <zip>11040</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mother and Child Health Care Inst &quot;Dr Vukan Cupic&quot;</name>
      <address>
        <city>Belgrade</city>
        <zip>11070</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clin Hosp Ctr Zemun - Cardiology Dept</name>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Univ Vall D'Hebron - Dpt Congenital Heart Disease Adult</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Univ Virgen Macarena - Dpt Cardiology</name>
      <address>
        <city>Sevilla</city>
        <zip>41007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Universitario La Fe Dpt Cardiology</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omu Pediatry</name>
      <address>
        <city>Samsun</city>
        <zip>55139</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Univ Hosp Congenital Heart Centre</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8BJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanoi Medical University Hospital</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital, Ho Chi Minh</name>
      <address>
        <city>Ho Chi Minh</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tam Duc Hospital</name>
      <address>
        <city>Ho Chi Minh</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Bulgaria</country>
    <country>Chile</country>
    <country>China</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
    <country>Vietnam</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>South Africa</country>
    <country>Taiwan</country>
  </removed_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 21, 2016</lastchanged_date>
  <firstreceived_date>November 29, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exercise capacity</keyword>
  <keyword>Eisenmenger Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Eisenmenger Complex</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Macitentan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
